Martin J. Edelman, MD

Department of Hematology/Oncology

This physician is not currently rated. Why?

Request an Appointment

Call 888-369-2427

Request Online

Clinical Locations

Primary Location
Fox Chase Cancer Center

Chair, Department of Hematology/Oncology

Professor, Department of Hematology/Oncology

Deputy Cancer Center Director for Clinical Research

G. Morris Dorrance Jr. Chair in Medical Oncology

Chair, Department of Medical Oncology, Lewis Katz School of Medicine at Temple University

Specialties

Research Program

Cancer Signaling and Microenvironment

Key Awards

Medical Oncology

Chair, Department of Hematology/Oncology

Dr. Edelman collaborates with our clinical, scientific, and administrative leadership to grow robust therapeutic, clinical research, and translational research programs in hematology and medical oncology while leading the department in evaluating emerging national trends in the delivery of care to cancer patients. In addition, Dr. Edelman is Deputy Cancer Center Director for Clinical Research, assisting a strong investigator-initiated clinical trials program.

A nationally recognized expert in the treatment and research of lung cancer, Dr. Edelman developed one of the most commonly used regimens for treating advanced lung cancer and has focused on the development of new agents and biomarkers to personalize lung cancer therapy. He has a particular interest in approaches that integrate surgery, radiation, and chemotherapy in the management of lung cancer patients.

Dr. Edelman serves on the Lung Cancer Committee of the Alliance (previously CALGB), the Board of Directors of the Alliance for Clinical Trials in Oncology, and the Thoracic Malignancies Steering Committee of the National Cancer Institute’s Scientific Review Group. In addition, he is the Medical Oncology Co-chair for the Lung Cancer Committee of the Radiation Therapy Oncology Group (RTOG) and is an active member and past chair of the Career Development and Ethics Committees of the International Association for the Study of Lung Cancer (IASLC).

Dr. Edelman has published more than 325 scientific articles, abstracts, and book chapters. In addition, he has served on the editorial boards or as an ad-hoc reviewer of numerous academic journals, including the New England Journal of Medicine and the Journal of Clinical Oncology, and currently serves as Associate Editor of the journal Lung Cancer.

Educational Background

Postdoctoral Scholar, University of California, San Diego, CA 1990
Fellowship, Hematology/Oncology, Naval Hospital, San Diego, CA 1990
Residency, Internal Medicine, Naval Hospital, San Diego, CA, 1986
Internship, Internal Medicine, Naval Hospital, San Diego, CA, 1983
MD, The Albany Medical College, Albany, NY, 1982
BS, Biology (cum laude), Rensselaer Polytechnic Institute, Troy, NY, 1982

Certifications

American Board of Internal Medicine, subspecialty certificate in Hematology 1990
American Board of Internal Medicine, subspecialty in Medical Oncology 1989
American Board of Internal Medicine 1986
National Board of Medical Examiners 1983

Memberships

American Society for Clinical Oncology
European Society of Medical Oncology
International Association for the Study of Lung Cancer
Thoracic Malignancies Steering Committee of the National Cancer Institute
Lung Cancer Committee of the Radiation Therapy Oncology Group (RTOG, NRG): Medical Oncology Co-Chair

Honors & Awards

Philadelphia Magazine Top Doctors, 2018-22
America's Top Doctors^®, 2017
Fellow, American College of Physicians 2011
Teaching Award, Department of Medicine, University of Maryland 2010
Award from Undersecretary of VA for Health Affairs 1998

Research Interests

Thoracic oncology malignancies; lung metastases

The following ratings and reviews are based on verified feedback collected from independently administered patient experience surveys. The ratings and comments submitted by patients reflect their own views and opinions. Patient identities are withheld to ensure confidentiality and privacy. Learn more about our Patient Experience Ratings.